Filtros : "Illes, Peter" Limpar

Filtros



Refine with date range


  • Source: Neurobiology of Disease. Unidade: IQ

    Subjects: TRANSTORNOS MENTAIS, DOENÇAS NEURODEGENERATIVAS, RECEPTORES

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ILLES, Peter et al. Purinergic receptors in cognitive disturbances. Neurobiology of Disease, v. 185, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.nbd.2023.106229. Acesso em: 30 abr. 2024.
    • APA

      Illes, P., Ulrich, H., Chen, J. F., & Tang, Y. (2023). Purinergic receptors in cognitive disturbances. Neurobiology of Disease, 185, 1-16. doi:10.1016/j.nbd.2023.106229
    • NLM

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
    • Vancouver

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
  • Unidade: IQ

    Subjects: RECEPTORES, NUCLEOTÍDEOS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ULRICH, Henning e ILLES, Peter e GLASER, Talita. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. . Cham: Springer. . Acesso em: 30 abr. 2024. , 2023
    • APA

      Ulrich, H., Illes, P., & Glaser, T. (2023). Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. Cham: Springer.
    • NLM

      Ulrich H, Illes P, Glaser T. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. 2023 ;[citado 2024 abr. 30 ]
    • Vancouver

      Ulrich H, Illes P, Glaser T. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. 2023 ;[citado 2024 abr. 30 ]
  • Source: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Unidade: IQ

    Subjects: NEURÔNIOS, SISTEMA NERVOSO CENTRAL

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAETANO, Roberta Andrejew et al. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Tradução . Cham: Springer, 2023. . . Acesso em: 30 abr. 2024.
    • APA

      Caetano, R. A., Turrini, N., Ye, Q., Tang, Y., Illes, P., & Ulrich, H. (2023). Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer.
    • NLM

      Caetano RA, Turrini N, Ye Q, Tang Y, Illes P, Ulrich H. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2024 abr. 30 ]
    • Vancouver

      Caetano RA, Turrini N, Ye Q, Tang Y, Illes P, Ulrich H. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2024 abr. 30 ]
  • Source: Frontiers in Pharmacology. Unidade: IQ

    Subjects: PURINAS, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CIRUELA, Francisco et al. Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fphar.2021.768923. Acesso em: 30 abr. 2024. , 2021
    • APA

      Ciruela, F., Fuxe, K., Illes, P., Ulrich, H., & Caciagli, F. (2021). Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2021.768923
    • NLM

      Ciruela F, Fuxe K, Illes P, Ulrich H, Caciagli F. Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial] [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-3.[citado 2024 abr. 30 ] Available from: https://doi.org/10.3389/fphar.2021.768923
    • Vancouver

      Ciruela F, Fuxe K, Illes P, Ulrich H, Caciagli F. Purinergic Signaling 2020: the state-of-the-art commented by the members of the Italian Purine Club [Editorial] [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-3.[citado 2024 abr. 30 ] Available from: https://doi.org/10.3389/fphar.2021.768923
  • Source: Signal Transduction and Targeted Therapy. Unidade: IQ

    Subjects: PURINAS, DOENÇAS NEURODEGENERATIVAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HUANG, Zhao et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, v. 6, p. 1-20 art. 162, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41392-021-00553-z. Acesso em: 30 abr. 2024.
    • APA

      Huang, Z., Xie, N., Illes, P., Virgilio, F. D., Ulrich, H., Semyanov, A., et al. (2021). From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, 6, 1-20 art. 162. doi:10.1038/s41392-021-00553-z
    • NLM

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
    • Vancouver

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
  • Source: Purinergic Signalling. Unidade: IQ

    Subjects: RECEPTORES, ADENOSINA TRIFOSFATO, FARMACOLOGIA, BIOQUÍMICA, BIOLOGIA MOLECULAR

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WANG, Tao et al. Optical control of purinergic signaling. Purinergic Signalling, v. 17, p. 385–392, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11302-021-09799-2. Acesso em: 30 abr. 2024.
    • APA

      Wang, T., Ulrich, H., Semyanov, A., Illes, P., & Tang, Y. (2021). Optical control of purinergic signaling. Purinergic Signalling, 17, 385–392. doi:10.1007/s11302-021-09799-2
    • NLM

      Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
    • Vancouver

      Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
  • Source: Neuroscience Bulletin. Unidade: IQ

    Subjects: ANALGÉSICOS, DOR

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      REN, Wen-Jing et al. TASK-3: new target for pain-relief. Neuroscience Bulletin, v. 36, n. 8, p. 951–954, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00516-4. Acesso em: 30 abr. 2024.
    • APA

      Ren, W. -J., Ulrich, H., Semyanov, A., Illes, P., & Tang, Y. (2020). TASK-3: new target for pain-relief. Neuroscience Bulletin, 36( 8), 951–954. doi:10.1007/s12264-020-00516-4
    • NLM

      Ren W-J, Ulrich H, Semyanov A, Illes P, Tang Y. TASK-3: new target for pain-relief [Internet]. Neuroscience Bulletin. 2020 ; 36( 8): 951–954.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1007/s12264-020-00516-4
    • Vancouver

      Ren W-J, Ulrich H, Semyanov A, Illes P, Tang Y. TASK-3: new target for pain-relief [Internet]. Neuroscience Bulletin. 2020 ; 36( 8): 951–954.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1007/s12264-020-00516-4
  • Source: Neuroscience Bulletin. Unidade: IQ

    Subjects: RECEPTORES, DOENÇA DE PARKINSON, DOENÇAS DOS GÂNGLIOS DE BASE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GLASER, Talita et al. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, v. 36, n. 11, p. 1299–1314, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00582-8. Acesso em: 30 abr. 2024.
    • APA

      Glaser, T., Andrejew, R., Giacomelli, Á. O., Ribeiro, D. E., Marques, L. B., Ye, Q., et al. (2020). Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, 36( 11), 1299–1314. doi:10.1007/s12264-020-00582-8
    • NLM

      Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1007/s12264-020-00582-8
    • Vancouver

      Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1007/s12264-020-00582-8
  • Source: Neural Regeneration Research. Unidade: IQ

    Subjects: DIFERENCIAÇÃO CELULAR, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ULRICH, Henning e ILLES, Peter. P2X receptors in maintenance and differentiation of neural progenitor cells. Neural Regeneration Research, v. 9, n. 23, p. 2040-2041, 2014Tradução . . Disponível em: https://doi.org/10.4103/1673-5374.147925. Acesso em: 30 abr. 2024.
    • APA

      Ulrich, H., & Illes, P. (2014). P2X receptors in maintenance and differentiation of neural progenitor cells. Neural Regeneration Research, 9( 23), 2040-2041. doi:10.4103/1673-5374.147925
    • NLM

      Ulrich H, Illes P. P2X receptors in maintenance and differentiation of neural progenitor cells [Internet]. Neural Regeneration Research. 2014 ; 9( 23): 2040-2041.[citado 2024 abr. 30 ] Available from: https://doi.org/10.4103/1673-5374.147925
    • Vancouver

      Ulrich H, Illes P. P2X receptors in maintenance and differentiation of neural progenitor cells [Internet]. Neural Regeneration Research. 2014 ; 9( 23): 2040-2041.[citado 2024 abr. 30 ] Available from: https://doi.org/10.4103/1673-5374.147925

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024